EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.

被引：0
|
作者：
Cho, H. [1 ]
Cho, D. [1 ]
Yeo, C. [1 ]
Bae, S. [1 ]
Shon, J. [1 ]
Park, S. [1 ]
Kim, E. [1 ]
Shin, J. [1 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] LACK OF A PHARMACOKINETIC INTERACTION BETWEEN ERTUGLIFLOZIN AND SITAGLIPTIN OR METFORMIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Matschke, K.
    Shi, H.
    Alvey, C.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Zhou, S.
    Krishna, R.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [22] The effect of dofetilide on the steady-state PK and cardiac effects of phenytoin in healthy subjects.
    Vincent, J
    Gardner, M
    Scavone, J
    Ashton, H
    Willavize, S
    Friedman, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV69 - PIV69
  • [23] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION OF DRONEDARONE AND NISOLDIPINE IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Sultan, Eric
    Allison, Mark
    Levene, Francoise
    Alberini, Helene
    Gaud, Christine
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1082 - 1082
  • [24] Pharmacokinetic and pharmacodynamic interaction of eszopiclone and paroxetine in healthy subjects.
    Skolly, SM
    Niewoehner, J
    Maier, G
    PHARMACOTHERAPY, 2004, 24 (10): : 1422 - 1422
  • [25] Pharmacokinetic and pharmacodynamic interaction of eszopiclone and lorazepam in healthy subjects.
    Niewoehner, J
    Anderson, AJ
    Maier, G
    PHARMACOTHERAPY, 2004, 24 (10): : 1421 - 1421
  • [26] PHARMACOKINETIC INTERACTION BETWEEN TELMISARTAN AND CHLORTHALIDONE AT STEADY-STATE IN HEALTHY KOREAN MALE VOLUNTEERS.
    Seong, S.
    Lim, M.
    Park, J.
    Lee, J.
    Park, S.
    Seo, J.
    Gwon, M.
    Lee, H.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S66 - S66
  • [27] Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects
    Liu, Ping
    Foster, Grover
    Gandelman, Kuan
    LaBadie, Robert R.
    Allison, Mark J.
    Gutierrez, Maria J.
    Sharma, Amarnath
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) : 3617 - 3626
  • [28] PHARMACOKINETIC INTERACTION BETWEEN TEGOPRAZAN AND METRONIDAZOLE/TETRACYCLINE/BISMUTH IN HEALTHY KOREAN SUBJECTS.
    Kim, M.
    Jeong, Y.
    Park, J.
    Moon, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S59 - S59
  • [29] The pharmacokinetic interaction between clarithromycin and TMC114/ritonavfr in healthy subjects.
    Sekar, VJ
    Guzman, S
    De Pauw, M
    De Paepe, E
    Vangeneugden, T
    Hoetelmans, R
    Lefebvre, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [30] A STUDY OF PHARMACOKINETIC INTERACTION BETWEEN BUSPIRONE AND ALPRAZOLAM AT STEADY-STATE
    BUCH, AB
    VANHARKEN, DR
    SEIDEHAMEL, RJ
    BARBHAIYA, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (11): : 1104 - 1109
12345